About Genpro Research
Genpro Research is a company based in Waltham (United States) founded in 2016 was acquired by Catalyst Clinical Research in July 2023. The company has 126 employees as of March 27, 2024. Genpro Research operates in a competitive market with competitors including Tredence, Cigniti, Cambridge Consultants, Nara Logics and Kovio, among others.
- Headquarter Waltham, United States
- Employees 126 as on 27 Mar, 2024
-
Sectors
Technology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Flex And Oncology Clinical Research Private Limited
- Date of Incorporation 04 Jul, 2019
- Jurisdiction Thiruvananthapuram, Kerala, India
-
Annual Revenue
$2.75 M (USD)77.78as on Mar 31, 2024
-
Net Profit
$176.25 K (USD)302.06as on Mar 31, 2024
-
EBITDA
$353.51 K (USD)252.01as on Mar 31, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
126
as on Mar 27, 2024
-
Acquired by
Catalyst Clinical Research
(Jul 21, 2023)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
People of Genpro Research
Unlock access to complete
Unlock access to complete
Scientific Team
4 people
Leadership Team
2 people
Sales and Marketing
2 people
Operations Team
1 people
Unlock access to complete
Funding Insights of Genpro Research
Detailed funding history for Genpro Research
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Genpro Research
Genpro Research has secured backing from 1 investor. Prominent investors backing the company include Catalyst Clinical Research.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Full-service clinical research organization
|
Locked | Locked | Locked |
Investor details for Genpro Research
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Genpro Research
Investment portfolio details for Genpro Research
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Genpro Research
Detailed financials for Genpro Research
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Genpro Research Comparisons
Peer comparison for Genpro Research
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Genpro Research
Genpro Research operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tredence, Cigniti, Cambridge Consultants, Nara Logics and Kovio, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI consulting, supply chain, and customer analytics services are provided.
|
|
| Locked | Locked | Locked |
Independent software testing services are provided with proprietary tools.
|
|
| Locked | Locked | Locked |
Deep tech innovation and product development services are provided.
|
|
| Locked | Locked | Locked |
AI and natural language processing services are provided.
|
|
| Locked | Locked | Locked |
Printed silicon electronics are developed for semiconductor products.
|
|
| Locked | Locked | Locked |
Offers systems integration, managed IT, cybersecurity, and digital transformation services.
|
Detailed competitors of Genpro Research
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Genpro Research
Complete news archive for Genpro Research
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genpro Research
Genpro Research was founded in 2016.
Genpro Research is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
As of Mar 27, 2024, the latest employee count at Genpro Research is 126.
Annual revenue of Genpro Research is $2.75M as on Mar 31, 2024.
Genpro Research was founded in 2016 and is based in Waltham, United States. Operations are centered on the technology sector, where natural language processing, software development, and big data services are delivered to clients. The company supports various applications through its domain expertise, with activities conducted primarily in the U.S. market. Focus remains on practical implementations of these technologies for business needs.
Genpro Research's top competitors include Tredence, Cigniti and Nara Logics.
Genpro Research has 1 investor. Key investors include Catalyst Clinical Research.